Nkarta Therapeutics Funding & Investors
Nkarta, Inc. operates as a biotech company. The Company develops and discovers therapies for immune systems and cancer indications. Nkarta serves patients in the State of California.
nkartatx.comTotal Amount Raised: $595,000,000
Nkarta Therapeutics Funding Rounds
Post Ipo Equity
$240,000,000
Post Ipo Equity Investors
Boxer CapitalSamsara BioCapitalCormorant Asset ManagementRidgeback CapitalJanus HendersonCommodore CapitalAdage Capital ManagementOrbiMed AdvisorsSr OneRa Capital ManagementEcoR1 CapitalPost Ipo Equity
$230,000,000
Series B
$114,000,000
Series B Investors
Samsara BioCapitalRa Capital ManagementLogos CapitalLSP (Life Sciences Partners)Deerfield ManagementAmgenNovo HoldingsNew Enterprise Associates (NEA)Sr OneSeries A
$11,000,000
Series A Investors
New Enterprise Associates (NEA)Novo HoldingsSr One
Funding info provided by Diffbot.